RU2016150783A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016150783A3 RU2016150783A3 RU2016150783A RU2016150783A RU2016150783A3 RU 2016150783 A3 RU2016150783 A3 RU 2016150783A3 RU 2016150783 A RU2016150783 A RU 2016150783A RU 2016150783 A RU2016150783 A RU 2016150783A RU 2016150783 A3 RU2016150783 A3 RU 2016150783A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2016150783A RU2663929C2 (en) | 2016-12-22 | 2016-12-22 | Use of thiochromeno[2,3-c]quinoline-12-one compound for treating non-small cells lung cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2016150783A RU2663929C2 (en) | 2016-12-22 | 2016-12-22 | Use of thiochromeno[2,3-c]quinoline-12-one compound for treating non-small cells lung cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016150783A3 true RU2016150783A3 (en) | 2018-06-22 |
| RU2016150783A RU2016150783A (en) | 2018-06-22 |
| RU2663929C2 RU2663929C2 (en) | 2018-08-13 |
Family
ID=62713179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016150783A RU2663929C2 (en) | 2016-12-22 | 2016-12-22 | Use of thiochromeno[2,3-c]quinoline-12-one compound for treating non-small cells lung cancer |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2663929C2 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2068880T1 (en) * | 2006-09-18 | 2012-08-31 | Boehringer Ingelheim Int | Method for treating cancer harboring egfr mutations |
| US8445529B2 (en) * | 2008-07-14 | 2013-05-21 | Santen Pharmaceutical Co., Ltd. | Indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| US8927717B1 (en) * | 2014-02-14 | 2015-01-06 | National Defense Medical Center | Thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof |
-
2016
- 2016-12-22 RU RU2016150783A patent/RU2663929C2/en active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2663929C2 (en) | 2018-08-13 |
| RU2016150783A (en) | 2018-06-22 |